Plain-English translation of NCT04888039 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Myeloma research guide →This is a research study that follows patients with multiple myeloma over time to understand how they are cared for and how well different treatments work. Researchers will review your medical records and track your health over several years to learn what helps patients live better lives with myeloma and what factors predict how well treatment works.
Multiple myeloma treatment has many different options, but doctors need better information about which approaches work best for different patients and how to improve quality of life during treatment. This study will help doctors in your region provide better, more personalized care based on real-world patient experiences.
You likely qualify if…
You likely don't qualify if…
You would allow researchers to access and review your medical records and follow your health information over time—potentially several years. There are no special visits or procedures required beyond your normal myeloma care. Researchers will simply track your treatment responses, side effects, quality of life, and outcomes as part of this registry study.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
France
University Hospital, Toulouse
Collaborators
Institut National de la Santé Et de la Recherche Médicale, France, Takeda
Enrollment target
~2,000 participants
Started
December 2021
Primary completion
June 2031
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Aurore PERROT, MD
IUCT-Oncopole - Toulouse University Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.